These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 23829186

  • 1. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M, Santhosh A, Babu PR, Subrahmanyam CV.
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [Abstract] [Full Text] [Related]

  • 2. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P, Shendarkar G, Shaikh S, Balmukund Rathi P.
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of two polymorphs of lornoxicam.
    Zhang J, Tan X, Gao J, Fan W, Gao Y, Qian S.
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S, Gupta A, Prasad R, Singh S.
    Curr Drug Deliv; 2021 Jan; 18(1):88-100. PubMed ID: 32807053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
    Panzade P, Shendarkar G.
    Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol cocrystals with enhanced solubility and tabletability.
    Zhou Z, Li W, Sun WJ, Lu T, Tong HHY, Sun CC, Zheng Y.
    Int J Pharm; 2016 Jul 25; 509(1-2):391-399. PubMed ID: 27282539
    [Abstract] [Full Text] [Related]

  • 11. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA, Gupta RB.
    AAPS PharmSciTech; 2012 Dec 25; 13(4):1396-406. PubMed ID: 23054991
    [Abstract] [Full Text] [Related]

  • 12. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
    Li J, Wang L, Ye YQ, Fu X, Ren Q, Zhang H, Deng Z.
    Eur J Pharm Sci; 2016 Mar 31; 85():47-52. PubMed ID: 26836368
    [Abstract] [Full Text] [Related]

  • 13. Chrysin cocrystals: Characterization and evaluation.
    Chadha R, Bhalla Y, Nandan A, Chadha K, Karan M.
    J Pharm Biomed Anal; 2017 Feb 05; 134():361-371. PubMed ID: 27894779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
    Manin AN, Voronin AP, Drozd KV, Manin NG, Bauer-Brandl A, Perlovich GL.
    Eur J Pharm Sci; 2014 Dec 18; 65():56-64. PubMed ID: 25218047
    [Abstract] [Full Text] [Related]

  • 16. pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.
    Alhalaweh A, Roy L, Rodríguez-Hornedo N, Velaga SP.
    Mol Pharm; 2012 Sep 04; 9(9):2605-12. PubMed ID: 22867056
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An experimental and theoretical investigation of loperamide hydrochloride-glutaric acid cocrystals.
    Bruni G, Maietta M, Maggi L, Mustarelli P, Ferrara C, Berbenni V, Freccero M, Scotti F, Milanese C, Girella A, Marini A.
    J Phys Chem B; 2013 Jul 11; 117(27):8113-21. PubMed ID: 23763498
    [Abstract] [Full Text] [Related]

  • 19. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties.
    Tsutsumi S, Iida M, Tada N, Kojima T, Ikeda Y, Moriwaki T, Higashi K, Moribe K, Yamamoto K.
    Int J Pharm; 2011 Dec 15; 421(2):230-6. PubMed ID: 21983091
    [Abstract] [Full Text] [Related]

  • 20. Crystal modifications and dissolution rate of piroxicam.
    Lyn LY, Sze HW, Rajendran A, Adinarayana G, Dua K, Garg S.
    Acta Pharm; 2011 Dec 15; 61(4):391-402. PubMed ID: 22202198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.